Find Academic Supervisors

Eddy UView profile

Professor

• Political Sociology
• Social Change
• Social Organization
• +5 more

Eddy U is a Professor of Sociology and Director of East Asian Studies at the University of California, Davis. His research focuses on political sociology, social change, and Chinese socialism, particularly examining classification systems and societal structures in 20th-century China. Key works include Creating the Intellectual: Chinese Communism and the Rise of a Classification (2019) and Disorganizing China: Counter-Bureaucracy and the Decline of Socialism (2007). He holds a Ph.D. from UC Berkeley and has taught courses on global social change and contemporary China. His academic journey began in Hong Kong, leading to a career blending theoretical sociology with empirical analysis of Chinese history. Current research explores the Cultural Revolution’s dynamics. Eddy U’s affiliations include the College of Letters and Science, with offices at 1 Shields Ave. Contact: eu@ucdavis.edu. Despite no listed students or awards, his scholarly contributions span books, edited volumes, and journal articles analyzing Marxist class formations, bureaucratic organization, and knowledge production in modern China. Recent work addresses the reification of social categories and intellectual identity in revolutionary contexts.

Abdul Salam VahithaView profile

Senior Lecturer

• Vascular Pharmacology
• Proteomics-Based Biomarker Discovery
• AI-Driven Drug Development
• +3 more

Dr. Abdul Salam Vahitha is a Senior Lecturer and Deputy Dean for Global Engagement & Partnerships at Queen Mary University of London's Faculty of Medicine and Dentistry. She leads the Vascular Pharmacology research group at the William Harvey Research Institute, focusing on vascular dysfunction mechanisms and translational drug discovery. Her roles include editorial board memberships at Frontiers in Cardiovascular Medicine and teaching drug design modules for undergraduate and postgraduate students. Education: BPharm (First Class Honors, National University of Malaysia), PhD (Imperial College London). Awards include the Pfizer European Young Investigator Award (2011) and Barts Charity Rising Stars Lectureship (2020). Her research integrates proteomics, AI, and environmental health studies to address cardiovascular diseases, microplastic impacts, and pulmonary hypertension. Key Research Themes: CLIC proteins in vascular remodeling Proteomics-based biomarker discovery AI-driven drug development Microplastics' cardiovascular risks Collaborations: Imperial College London, Karolinska Institute, Water Research Centre Ltd Grants: Barts Charity, Innovate UK, Alan Turing Institute Her lab investigates CLIC proteins' roles in diseases like PAH and atherosclerosis while developing targeted therapies. She also explores environmental pollutants' effects on vascular health, contributing to public health strategies.

Konrad ZinsmaierView profile

Professor

• Neuroscience
• Neurodegenerative Diseases
• Molecular Biology
• +3 more

Konrad Zinsmaier is a Professor and Department Head at the University of Arizona, where he leads research on synaptic function and neurodegenerative mechanisms. His work combines molecular biology and genetics in Drosophila models to study synaptic plasticity, mitochondrial dynamics, and neuroprotective pathways. His research focuses on mechanisms maintaining synaptic integrity, including roles of cysteine-string protein (CSP) in preventing neurodegeneration and DCAF12’s involvement in ubiquitination pathways. Key projects include modeling neuronal ceroid lipofuscinosis (CLN4) and investigating mitochondrial transport via Miro GTPases. Publications highlight contributions to understanding ALS, Parkinson’s disease mechanisms, and synaptic vesicle recycling. His studies bridge basic neuroscience with disease modeling, emphasizing translational potential for neuroprotective therapies. Teaching responsibilities include courses on neurogenetics, cellular neurobiology, and neuroscience methodology. Research also extends to cryopreservation techniques for primary neurons and olfactory receptor function in Drosophila . Labs: Automated Analysis of Mitochondrial x-y-t Tracks focuses on real-time mitochondrial dynamics and signaling.

• Cardiovascular Physiology
• Stem Cells
• Sex differences in stem cells and cardiac physiology
• +3 more

Ketul Chaudhary is an Assistant Professor in the Department of Physiology and Biophysics at Dalhousie University's Faculty of Medicine. His research focuses on cardiovascular physiology, stem cells, and sex-based differences in cardiac and vascular biology. He leads a lab investigating mechanisms underlying right heart failure, pulmonary hypertension, and microvascular loss in severe pulmonary arterial hypertension (PAH). Current training opportunities include PhD and postdoctoral positions starting in 2026. Education: BPharm, Hemchandracharya North Gujarat University PhD, University of Alberta Postdoctoral Fellowship, Ottawa Hospital Research Institute/University of Ottawa Research Interests: Dr. Chaudhary’s work emphasizes understanding sex as a biological variable in health and disease, particularly in PAH and cardiac physiology. His lab explores stem cell therapies, vascular remodeling, and molecular pathways (e.g., SOX17, BMP9) influencing disease progression. Key models include rat strains (e.g., Fischer CDF, Sprague-Dawley) and genetic interventions to study right ventricular adaptation. Publications: Recent work includes studies on right ventricular remodeling, therapeutic efficacy of treprostinil, and genetic determinants of PAH susceptibility. His research highlights novel mechanisms in pulmonary vascular disease, such as SOX17 deficiency and sex hormone modulation. Labs & Teams: The Chaudhary Lab focuses on translational cardiovascular research, collaborating with institutions like the Ottawa Hospital Research Institute. Ongoing projects involve optimizing cell-based therapies (e.g., microencapsulated endothelial progenitor cells) and imaging techniques (e.g., micro-CT) to study lung microvasculature.

Anne Berit JohnsenView profile

Associate Professor

• Cardiac Electrophysiology
• MicroRNA Regulation
• Exercise Physiology
• +5 more

Anne Berit Johnsen is an Associate Professor at the Norwegian University of Science and Technology (NTNU), affiliated with the Department of Teacher Education. Her research focuses on cardiac electrophysiology, particularly the molecular mechanisms underlying sinus bradycardia and ion channel remodeling induced by exercise training. She investigates the role of microRNAs (e.g., miR-423-5p) and transcription factors (e.g., Nkx2.5) in regulating pacemaking ion channels like HCN4, which contribute to heart rate adaptations in athletes and potential implications for sinus node dysfunction. Her work includes studies on human athletes and rodent models, demonstrating how miRNA dysregulation impacts heart rate and ion channel expression. Despite her academic role, no explicit information on educational background, grants, or student advisees is provided in the text. Research interests include the interplay between exercise physiology, microRNA regulation, ion channel dynamics, and their clinical relevance in cardiovascular conditions. Findings from her studies suggest miR-423-5p as a therapeutic target for pathological sinus node dysfunction in veteran athletes, highlighting novel pathways in cardiac electrophysiological adaptation. No scientific awards or grants are explicitly mentioned in the text. Collaborations with institutions like the Institute of Circulation and Imaging (as inferred from her co-authored publication) are noted, but her primary affiliation remains the Department of Teacher Education at NTNU.

Michael J. BursteinView profile

Professor

• Intellectual Property Law
• Innovation Policy
• Entrepreneurship Law
• +3 more

Michael J. Burstein is a Professor of Law at Cardozo School of Law, Yeshiva University, specializing in intellectual property, innovation policy, and law and entrepreneurship. He served as Vice Dean from 2018–2023. His research examines how legal frameworks influence innovation ecosystems, corporate behavior, and government interactions. Prior roles include McKinsey & Company’s Knowledge Lead for the Growth Technology practice (2016–2018), a Climenko Fellow at Harvard Law School, and a law clerk for the U.S. Court of Appeals for the D.C. Circuit. Education: B.A. in Molecular Biophysics & Biochemistry and Ethics, Politics & Economics from Yale University (1999); J.D. from New York University School of Law (2004, magna cum laude). Research focuses on non-IP strategies for information exchange, patent markets, and innovation prizes. His interdisciplinary work bridges legal analysis with empirical methods to address challenges in tech startups and venture capital ecosystems. He has contributed to understanding the legal and economic drivers of collaborative innovation. Professional trajectory includes appellate litigation in Washington, D.C., and service in the U.S. Department of Justice’s Office of the Solicitor General. His career reflects a blend of academia, private practice, and policy influence.

Franklin ZhongView profile

Assistant Professor

• Immunology
• Innate Immune System
• Skin Diseases
• +5 more

Franklin Zhong is an Assistant Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. He holds a PhD in Cancer Biology from Stanford University and a Bachelor's in Natural Sciences from the University of Cambridge, UK. His research focuses on the innate immune system in barrier tissues, particularly the skin, aiming to uncover mechanisms of inflammation and cancer immune-surveillance linked to microbial infections and autoimmune diseases. Key areas include ribotoxic stress responses, NLRP1 inflammasome activation, and therapeutic targets for skin diseases like atopic dermatitis and chronic wounds. Affiliations: Lee Kong Chian School of Medicine, Skin Research Institute of Singapore. Research Themes: Innate immunity, inflammasome biology, skin barrier function, microbial pathogenesis. His work bridges basic science and translational medicine, collaborating with clinicians and industry partners to advance treatments for skin disorders and infectious diseases. Notable contributions include identifying NLRP1 inflammasome pathways in response to bacterial toxins and UV radiation, and developing cholesterol biosensors to study skin membrane dynamics. Labs/Teams: Skin Diseases & Wound Repair Program at LKCMedicine, collaborating with National Skin Centre and Skin Research Institute of Singapore.

Natasha KhovanovaView profile

Professor

• System identification
• Glucose dynamics modeling
• Cardio-respiratory coupling
• +3 more

Professor Natasha Khovanova is Director of Graduate Studies in the University of Warwick's School of Engineering and holds an EPSRC Fellowship. With joint appointments in Systems and Information Engineering and University Hospital Coventry, her research develops computational approaches for healthcare challenges including diabetes management and transplant outcomes. Education includes: PhD in Physical and Mathematical Sciences from Saratov State University Research programs focus on: Physiological modeling of glucose dynamics for gestational diabetes diagnosis Cardio-respiratory synchronization analysis in athletes Machine learning for clinical data limitations in renal transplantation Donor-specific antibody pathogenicity modeling Recent publications demonstrate innovations in C3d biomarker stratification for transplant rejection risk and continuous glucose monitoring algorithms. Current projects include in-ear health monitoring devices and Long COVID progression prediction. Honored with EPSRC Fellowship supporting her gestational diabetes research program. Teaching includes system modeling/control courses and research project supervision. Leads multiple collaborative projects with NHS Trusts and industry partners including Dexcom and Siemens.

• Biophysics
• Cellular Biology
• Ion Pump Mechanisms
• +3 more

Hjalmar Brismar is a Professor of Experimental Biological Physics at the Department of Applied Physics, KTH Royal Institute of Technology. He also serves as Director of the Cellular and Molecular Imaging Platform at the Science for Life Laboratory and coordinates the National Microscopy Infrastructure (NMI). His research focuses on understanding cellular dynamics through the study of Na,K-ATPase ion pumps and advanced microscopy techniques. He holds a CivIng (1991) and PhD (1996) in Engineering Physics from KTH, followed by postdoctoral training at Harvard University. Research interests include Na,K-ATPase signaling, calcium oscillations, and the development of super-resolution microscopy. Key projects involve the pump's role in cellular stress response and apoptosis, as well as innovations in microscopy for biomedical applications. His team collaborates across KTH and Karolinska Institutet, integrating light microscopy with cell and molecular biology. Recent articles highlight advancements in imaging techniques, ion pump regulation, and pathological mechanisms in kidney and neurological diseases. Awards include membership in the Royal Swedish Academy of Engineering Sciences (2010) and leadership roles in national and international microscopy initiatives. Brismar has supervised 15 PhD students, 8 Licentiate candidates, and 48 M.Sc. theses, reflecting his extensive mentorship in biophysical research. Labs/Teams: Leader of the national super-resolution microscopy infrastructure at SciLifeLab, Swedish node in EurobioImaging, and core member of the Brismar Lab focusing on cellular biophysics and imaging innovation.

• Cell Biology
• Renal Physiology
• Ion Channel Biology
• +5 more

Marina Zelenina is a Lecturer at KTH Royal Institute of Technology's Department of Bio-Opto-Nano Fysik. She specializes in the regulation of aquaporins and ion channels in physiological and pathological contexts, with a focus on brain, renal, and neonatal systems. Her research integrates biophysical techniques, cell biology, and clinical applications. Key areas of focus include aquaporin-mediated water transport mechanisms, heavy metal toxicity effects on cellular hydration, and neuroprotective strategies involving astrocyte function. She is actively involved in teaching a wide range of physics and biomedical engineering courses, serving as course responsible, examiner, and instructor for over 15 academic programs at KTH. Research interests emphasize the molecular mechanisms governing water and ion transport across cell membranes, particularly in neurological and renal contexts. Her work bridges basic science and clinical applications, addressing conditions such as congenital diaphragmatic hernia, cerebral edema, and postnatal adaptation challenges. Technical expertise includes confocal microscopy-based permeability measurements and microfluidic device development for cell monitoring. Recent publications highlight advancements in understanding glutamate receptor modulation of astrocyte function, erythropoietin's role in neuroprotection, and the development of novel in situ cellular monitoring systems. Her contributions span peer-reviewed articles, conference presentations, and manuscripts exploring aquaporin roles in K+ transport and quantum dot interactions with epithelial barriers.

Sylvia PenderView profile

Associate Professor

• Immunology
• Cancer Research
• Medical Imaging
• +3 more

Dr Sylvia Pender is an Associate Professor at the University of Southampton, affiliated with the Institute for Life Sciences and the Centre for Human Development, Stem Cells and Regeneration. Her research focuses on colorectal cancer imaging, immunological mechanisms, and advanced biomedical visualization techniques. She has pioneered the use of synchrotron-based X-ray phase contrast tomography for early cancer detection and 3D cyclorama imaging for tissue morphology analysis. Dr. Pender’s work integrates molecular biology, computational imaging, and clinical applications. Projects: Received EU funding for IBDase and IPODD initiatives, and collaborated on studies involving mast cell interactions and nasal polyp formation. Awards: Recognized with the Best Poster Prize (2019), British Society Gastroenterology Awards (2017-2023), and Fellow of the Royal Society of Biology (2024). Her research has led to novel insights into mitochondrial dysfunction in T cells, bacterial survival mechanisms, and imaging protocols for early cancer biomarkers. She actively supervises PhD students like Murad Baabbad and presents at international conferences on imaging innovations and cancer research.

Charlotte SumnerView profile

Professor

• Developmental Neuroscience
• Cellular and Molecular Neuroscience
• Neurobiology of Disease
• +3 more

Charlotte Sumner, MD is a Professor of Neurology, Neuroscience, and Genetic Medicine at Johns Hopkins University School of Medicine. She leads a laboratory focused on genetic and molecular mechanisms underlying motor neuron diseases like spinal muscular atrophies (SMA) and Charcot-Marie-Tooth (CMT) disorders. Her research integrates clinical insights with preclinical models, emphasizing early therapeutic intervention strategies. Key areas of expertise include: TRPV4 ion channel dysfunction in neurodegeneration SMN protein biology in SMA pathogenesis Gene therapy development for neuromuscular disorders Neurovascular interactions in disease progression Her lab employs multidisciplinary approaches including human genetic studies, mouse models, cellular assays, and clinical specimen analysis. Current projects investigate novel genetic causes of motor neuron diseases, molecular mechanisms of axonal degeneration, and combination therapies for SMA. Recent work demonstrated endothelial barrier defects in TRPV4-related disorders and identified SMN-AS1 as a new therapeutic target. Lab personnel include postdoctoral fellow Elana Molotsky and graduate students Anna Bagnell (Cellular and Molecular Medicine), Jonathan Alevy (Neuroscience), Stephen Brown (Pathobiology), and Maddi Denton (Genetic Medicine). Collaborative networks span Johns Hopkins' departments of Neurology, Neuroscience, and Genetic Medicine.

Paul GriffinView profile

Associate Professor

• Infectious Diseases
• Clinical Microbiology
• Vaccine Development
• +5 more

Professor Paul Griffin is an Associate Professor of Medicine at the University of Queensland Medical School and Director of Infectious Diseases at Mater Health Services. He leads clinical research at Nucleus Network, overseeing over 125 clinical trials, including 8 COVID-19 vaccines and malaria studies. His expertise spans infectious diseases, clinical microbiology, and vaccine development. He chairs the Advanced Training Committee in Infectious Diseases for the Royal Australasian College of Physicians and advises the Immunisation Coalition. Key roles include medical directorships, media advocacy during the pandemic, and leadership in diagnostic microbiology, particularly metagenomic sequencing applications. Education: Fellowship in Infectious Diseases (Royal Australasian College of Physicians), Clinical Microbiology (Royal College of Pathologists of Australasia), and Tropical Medicine (Australasian College of Tropical Medicine). Research Interests: Focuses on vaccine development, antimicrobial resistance, malaria therapeutics, and public health strategies. His work integrates clinical trials, pathogen detection via metagenomics, and post-viral syndromes (e.g., Long COVID). Key projects include evaluating novel antimalarials, SARS-CoV-2 vaccine efficacy, and improving Clostridioides difficile infection management. His studies often bridge basic science and translational medicine. Recent publications highlight advancements in antimalarial agents, quantum computing for vaccine analytics, and post-COVID ion channel dysfunction. He collaborates globally, including with organizations like Nucleus Network and the WHO. Grants & Funding: Extensive grants supporting clinical trials, vaccine research, and tropical disease studies. Financial support includes industry partnerships (e.g., Novavax, Moderna) and government health initiatives. Labs/Teams: Leads the Mater Clinical Unit’s Infectious Diseases team and collaborates with Nucleus Network’s clinical trial platforms. Engages in multidisciplinary groups for metagenomic diagnostics and vaccine efficacy evaluations.

• Cardiovascular Science
• Atrial Fibrillation Mechanisms
• Cardiac Fibrosis
• +5 more

Svetlana Reilly is an Associate Professor of Cardiovascular Science and British Heart Foundation Senior Research Fellow at the University of Oxford's Radcliffe Department of Medicine. She leads the Reilly Group, focusing on molecular mechanisms underlying cardiac fibrosis and atrial fibrillation. Her work combines molecular biology, transcriptomics, and genetically modified mouse models to identify therapeutic targets. She is affiliated with the BHF Center of Research Excellence and the Queen's College, Oxford. Research interests include: 1) Cardiac fibrosis mechanisms involving calcitonin receptors and single-cell RNA sequencing of fibroblasts; 2) Atrial fibrillation pathogenesis, particularly calcium handling defects and LKB1 signaling pathways; 3) Translational research linking lab discoveries to clinical biomarkers. Publications highlight advanced methodologies like multi-omics analysis and collaborative work with institutions like the Montreal Heart Institute and Baylor College of Medicine. A recent focus is on androgen receptor signaling in atrial fibrillation and therapeutic development against SARS-CoV-2 cardiac effects. Her BHF-funded projects aim to translate molecular insights into clinical applications. Scientific recognition includes the BHF Senior Research Fellowship. Collaborations span structural biology (e.g., Diamond Light Source) and international cardiology institutions. Ongoing work explores calcitonin signaling mechanisms and new mouse models for arrhythmia research.

John ElrodView profile

Professor

• Cardiovascular Biology
• Mitochondrial Calcium Signaling
• Heart Failure
• +7 more

John Elrod, PhD, is a Professor and Director of the Aging + Cardiovascular Discovery Center at the Lewis Katz School of Medicine, Temple University. He leads a research laboratory focused on mitochondrial calcium signaling and its role in heart disease, particularly myocardial infarction and heart failure. His work integrates molecular, genetic, and systems biology approaches to uncover novel therapeutic targets. His research interests center on mitochondrial calcium exchange , genetic regulation of cell death , and metabolic dysfunction in cardiovascular disease . The Elrod lab utilizes genome-wide functional screening and genetically engineered mouse models to dissect the molecular mechanisms underlying necrosis and metabolic inflexibility in the heart. A major focus is on the mitochondrial permeability transition pore, the MCU complex, and NCLX-mediated calcium efflux. His recent publications reveal a strong trend toward understanding the metabolic-epigenetic axis in cardiac remodeling , organelle dynamics in heart failure , and mitochondrial calcium as a central regulator of cell fate . His work spans from basic mechanisms to translational models, including large animal studies of HFpEF. Postdoctoral Fellow, Cincinnati Children's Medical Hospital, Howard Hughes Medical Institute (2012) PhD, Pathology, Albert Einstein College of Medicine (2007) BS, Biology (cum laude), Centenary College (2002) Dr. Elrod has trained numerous researchers and collaborates extensively across disciplines. His lab has produced seminal work on hydrogen sulfide, nitric oxide, and mitochondrial calcium in cardioprotection. He has not received any explicitly listed scientific awards in the provided text, but his publication record in top-tier journals (Nature, PNAS, Circulation, Cell Metabolism) underscores significant recognition in the field. He is actively involved in mentoring students and postdoctoral fellows, though specific names are not listed. His lab operates at the intersection of cardiac metabolism , mitochondrial dynamics , and fibrotic remodeling , with a clear focus on identifying druggable pathways for heart disease. The Aging + Cardiovascular Discovery Center serves as a hub for interdisciplinary research under his directorship.